Shirley Liu Clayton
Direttore/Membro del Consiglio presso REGiMMUNE Corp.
Posizioni attive di Shirley Liu Clayton
Società | Posizione | Inizio | Fine |
---|---|---|---|
REGiMMUNE Corp.
REGiMMUNE Corp. Pharmaceuticals: MajorHealth Technology REGiMMUNE Corp. develops solutions for treating immune disorders. Its focus is on the discovery, development, and commercialization of immune regulatory therapeutics to treat life-threatening and debilitating conditions, including allergies, autoimmune diseases and transplantation. The firm's platform technology, reVax, induces immune tolerance in an antigen-specific manner through pharmacological induction of regulatory T (Treg) cells. It also develops products for preventing inhibitor formation in enzyme replacement therapies (ERT) and for celiac disease with undisclosed partners. The company was founded by Yasuyuki Ishii on March 3, 2006 and is headquartered in Tokyo, Japan. | Direttore/Membro del Consiglio | 01/02/2007 | - |
Storia della carriera di Shirley Liu Clayton
Precedenti posizioni note di Shirley Liu Clayton
Società | Posizione | Inizio | Fine |
---|---|---|---|
MetroCorp Bancshares, Inc.
MetroCorp Bancshares, Inc. Major BanksFinance MetroCorp Bancshares, Inc. is a bank holding company. The company, through its subsidiaries MetroBank NA and Metro United Bank, provides commercial banking products and services including, personal banking, savings account information, mortgage lending, commercial loans and cash management services. It offers commercial and industrial loans to wholesalers, manufacturers and business service companies, commercial mortgage loans to finance the purchase of real property; construction loans to finance the construction of residential and non-residential properties and government guaranteed small business lending products and services. The company provides trade finance and letters of credit for export and import transactions of small and medium-sized businesses, residential mortgage brokerage and lending and retail banking products and services. MetroCorp Bancshares was founded in 1998 and is headquartered in Houston, TX. | Direttore/Membro del Consiglio | 01/04/2004 | 22/01/2014 |
Independent Dir/Board Member | 01/04/2004 | 22/01/2014 | |
Abmaxis, Inc.
Abmaxis, Inc. Pharmaceuticals: MajorHealth Technology Abmaxis Inc. develops pharmaceutical drugs. The company discovers and optimizes monoclonal antibody (mAb) products for human therapeutics and diagnostics. It has developed antibody engineering technology platform, Abmaxis in-silico Immunization (AISIM TM), which they are used for building an internal product pipeline and collaboration with global biotech and pharmaceutical partners. The company was founded in 2000 and is located in Santa Clara, CA. | Presidente | 01/09/2003 | - |
CBYON, Inc. | Direttore Finanziario/CFO | 01/01/2000 | 01/01/2003 |
MERRILL LYNCH PREFERRED CAPITAL TRUST I | Corporate Officer/Principal | 01/01/1976 | 01/01/1981 |
Trellis Bioscience, Inc.
Trellis Bioscience, Inc. BiotechnologyHealth Technology Trellis Bioscience, Inc. is discovers and develops novel human antibody therapeutics. It provides the discovery and development of therapeutic antibodies from human B cells. The firm develops the CellSpot antibody discovery platform, which enables the identification of antibodies directly from human blood. The company was founded by Lawrence Kauvar and Stote Ellsworth in 1998 and is headquartered in South San Francisco, CA. | Direttore/Membro del Consiglio | - | - |
A-CUBE, Inc.
A-CUBE, Inc. BiotechnologyHealth Technology A-CUBE, Inc. develops novel antibodies. It utilizes silico algorithms and to discover novel druggable targets suitable for developing human therapeutic interventions, including next generation drugs for commercially proven targets. The company was founded by Nobuyuki Ota is headquartered in Belmont, CA. | Direttore/Membro del Consiglio | - | - |
Cygnus, Inc.
Cygnus, Inc. Medical SpecialtiesHealth Technology Cygnus, Inc. develops and manufactures glucose-monitoring devices. The company develops devices that provide data to individuals and physicians to enable them to manage diabetes. It was founded in 1985 and is headquartered in San Francisco, CA. | Presidente | - | - |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Direttore Finanziario/CFO | 15/07/2009 | - |
Presidente | - | 15/07/2009 | |
░░░░░░░ ░░░░░░ ░░░░░ ░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | - | - |
░░░░░░░░░ | - | - | |
░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░░░ ░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░ | ░░░░░░░░░░ | - | |
░░░░░░░░░ | ░░░░░░░░░░ | - |
Formazione di Shirley Liu Clayton
Smith College | Undergraduate Degree |
Stanford University | Masters Business Admin |
Statistiche
Distribuzione geografica
Stati Uniti | 15 |
Giappone | 2 |
Posizioni
Director/Board Member | 6 |
President | 5 |
Director of Finance/CFO | 4 |
Settori
Health Technology | 8 |
Finance | 5 |
Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
MERRILL LYNCH PREFERRED CAPITAL TRUST I | Finance |
Aziende private | 12 |
---|---|
MetroCorp Bancshares, Inc.
MetroCorp Bancshares, Inc. Major BanksFinance MetroCorp Bancshares, Inc. is a bank holding company. The company, through its subsidiaries MetroBank NA and Metro United Bank, provides commercial banking products and services including, personal banking, savings account information, mortgage lending, commercial loans and cash management services. It offers commercial and industrial loans to wholesalers, manufacturers and business service companies, commercial mortgage loans to finance the purchase of real property; construction loans to finance the construction of residential and non-residential properties and government guaranteed small business lending products and services. The company provides trade finance and letters of credit for export and import transactions of small and medium-sized businesses, residential mortgage brokerage and lending and retail banking products and services. MetroCorp Bancshares was founded in 1998 and is headquartered in Houston, TX. | Finance |
Abmaxis, Inc.
Abmaxis, Inc. Pharmaceuticals: MajorHealth Technology Abmaxis Inc. develops pharmaceutical drugs. The company discovers and optimizes monoclonal antibody (mAb) products for human therapeutics and diagnostics. It has developed antibody engineering technology platform, Abmaxis in-silico Immunization (AISIM TM), which they are used for building an internal product pipeline and collaboration with global biotech and pharmaceutical partners. The company was founded in 2000 and is located in Santa Clara, CA. | Health Technology |
Raven Biotechnologies, Inc.
Raven Biotechnologies, Inc. Miscellaneous Commercial ServicesCommercial Services Raven Biotechnologies, Inc. engages in the development of antibody therapeutics for the treatment for cancer, autoimmune disorders and infectious diseases. Its products are used in treatment of gastrointestinal, lung, colon, pancreatic, prostate, breast, brain, and ovarian cancer. The company was founded in 1999 and is headquartered in South San Francisco, CA. | Commercial Services |
MetroBank, NA (Houston, Texas)
MetroBank, NA (Houston, Texas) Major BanksFinance MetroBank NA operates as a national chartered commercial bank. The company is headquartered in Los Angeles, CA. | Finance |
Metro United Bank
Metro United Bank Regional BanksFinance Metro United Bank is a state chartered commercial bank. The company is based in San Diego, CA. | Finance |
CBYON, Inc. | |
Protein Design Labs, Inc.
Protein Design Labs, Inc. Pharmaceuticals: MajorHealth Technology Protein Design Labs, Inc. is a biopharmaceutical company focused on the research, development and commercialization of novel therapies for inflammation and autoimmune diseases, acute cardiac conditions and cancer. PDL markets several biopharmaceutical products in the United States through its hospital sales force and wholly-owned subsidiary, ESP Pharma, Inc. As a company of development of humanized antibodies, It has licensed its patents to numerous pharmaceutical and biotechnology companies, some of which are now paying royalties on net sales of licensed products. | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Cygnus, Inc.
Cygnus, Inc. Medical SpecialtiesHealth Technology Cygnus, Inc. develops and manufactures glucose-monitoring devices. The company develops devices that provide data to individuals and physicians to enable them to manage diabetes. It was founded in 1985 and is headquartered in San Francisco, CA. | Health Technology |
A-CUBE, Inc.
A-CUBE, Inc. BiotechnologyHealth Technology A-CUBE, Inc. develops novel antibodies. It utilizes silico algorithms and to discover novel druggable targets suitable for developing human therapeutic interventions, including next generation drugs for commercially proven targets. The company was founded by Nobuyuki Ota is headquartered in Belmont, CA. | Health Technology |
REGiMMUNE Corp.
REGiMMUNE Corp. Pharmaceuticals: MajorHealth Technology REGiMMUNE Corp. develops solutions for treating immune disorders. Its focus is on the discovery, development, and commercialization of immune regulatory therapeutics to treat life-threatening and debilitating conditions, including allergies, autoimmune diseases and transplantation. The firm's platform technology, reVax, induces immune tolerance in an antigen-specific manner through pharmacological induction of regulatory T (Treg) cells. It also develops products for preventing inhibitor formation in enzyme replacement therapies (ERT) and for celiac disease with undisclosed partners. The company was founded by Yasuyuki Ishii on March 3, 2006 and is headquartered in Tokyo, Japan. | Health Technology |
Trellis Bioscience, Inc.
Trellis Bioscience, Inc. BiotechnologyHealth Technology Trellis Bioscience, Inc. is discovers and develops novel human antibody therapeutics. It provides the discovery and development of therapeutic antibodies from human B cells. The firm develops the CellSpot antibody discovery platform, which enables the identification of antibodies directly from human blood. The company was founded by Lawrence Kauvar and Stote Ellsworth in 1998 and is headquartered in South San Francisco, CA. | Health Technology |
- Borsa valori
- Insiders
- Shirley Liu Clayton
- Esperienza